| Ytd | ||
| 1y |
| Open | 9.55 | Prev Close | 9.81 | Low | 9.55 | High | 10.32 | Mkt Cap | 54.80M |
| Vol | 9.40K | Avg Vol | 0.00 | EPS | N/A | P/E | N/A | Forward P/E | -1.48 |
| Beta | 0.74 | Short Ratio | 20.03 | Inst. Own | 41.80% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | N/A | 200-d Avg | N/A | 1yr Est | 1.50 |
Abbott Cooper PLLC is investigating fiduciary duty claims for Kalaris Therapeutics (formerly AlloVir
Valuation and Earnings This table compares SQZ Biotechnologies and AlloVir"s gross revenue, earnings
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered L
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Lo
NEW YORK, NY / ACCESS Newswire / June 15, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating
NEW YORK, NY / ACCESS Newswire / June 12, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating
NEW YORK, NY / ACCESS Newswire / June 10, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating
NEW YORK, NY / ACCESS Newswire / June 8, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating
NEW YORK, NY / ACCESS Newswire / June 5, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating
BOSTON, June 05, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that the United States Di
NEW YORK, NY / ACCESS Newswire / June 3, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating
NEW YORK, NY / ACCESS Newswire / May 29, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating
Kalaris is focused on developing TH103, a novel, differentiated anti-VEGF agent engineered to potent
Combined company expected to trade on Nasdaq under “KLRS” after closing Combined company expected to
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and th
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and th
NEW YORK, Nov. 09, 2024 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is invest
NEW YORK , Nov. 8, 2024 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigat
NEW YORK, Nov. 08, 2024 (GLOBE NEWSWIRE) -- Monteverde & Associates PC (the “M&A Class Action Firm”)
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analys
During Tuesday's session, 275 companies made new 52-week lows.
During Monday's session, 201 stocks hit new 52-week lows.
Gainers Aeglea BioTherapeutics, Inc. (NASDAQ: AGLE) shares climbed 422% to $0.5572 after the comp
Gainers Digital Media Solutions, Inc. (NYSE: DMS) jumped 78.8% to close at $2.11. Digital Media S
Gainers Blue Water Vaccines, Inc. (NASDAQ: BWV) shares climbed 53.2% to close at $3.14 on Wednes
Gainers
On Wednesday, 807 companies reached new 52-week lows.
On Monday, 721 companies achieved new lows for the year.
On Friday, 431 companies hit new 52-week lows.
On Monday, 466 companies hit new 52-week lows.
On Monday, 78 companies set new 52-week lows.
During Thursday's morning trading, 152 companies set new 52-week lows.
During Wednesday's morning trading, 400 companies set new 52-week lows.
Tuesday morning saw 454 companies set new 52-week lows.
On Thursday, 615 stocks hit new 52-week lows.
On Monday morning, 60 companies achieved new lows for the year.
During the morning session on Thursday, 152 stocks hit new 52-week lows.
Thursday morning, 158 companies reached new 52-week lows.
During Thursday's morning session, 92 stocks hit new 52-week lows.